Literature DB >> 24622383

Seeking a unique lipid signature predicting cardiovascular disease risk.

J Mark Brown1, Stanley L Hazen.   

Abstract

Entities:  

Keywords:  Editorials; atherosclerosis; cholesterol; lipids; triglycerides

Mesh:

Year:  2014        PMID: 24622383      PMCID: PMC4018580          DOI: 10.1161/CIRCULATIONAHA.114.009224

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  20 in total

1.  The effect on serum-cholesterol of diets containing different fats.

Authors:  H MALMROS; G WIGAND
Journal:  Lancet       Date:  1957-07-06       Impact factor: 79.321

Review 2.  ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia.

Authors:  Lawrence L Rudel; Richard G Lee; Paolo Parini
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-04-14       Impact factor: 8.311

Review 3.  The emerging role of plasma lipidomics in cardiovascular drug discovery.

Authors:  Rishi Puri; MyNgan Duong; Kiyoko Uno; Yu Kataoka; Stephen J Nicholls
Journal:  Expert Opin Drug Discov       Date:  2011-12-12       Impact factor: 6.098

4.  Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Emily L Willner; Bryan Tow; Kimberly K Buhman; Martha Wilson; David A Sanan; Lawrence L Rudel; Robert V Farese
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

Review 5.  Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome.

Authors:  Michael B Fessler; Lawrence L Rudel; J Mark Brown
Journal:  Curr Opin Lipidol       Date:  2009-10       Impact factor: 4.776

6.  Plasma lipid profiling in a large population-based cohort.

Authors:  Jacquelyn M Weir; Gerard Wong; Christopher K Barlow; Melissa A Greeve; Adam Kowalczyk; Laura Almasy; Anthony G Comuzzie; Michael C Mahaney; Jeremy B M Jowett; Jonathan Shaw; Joanne E Curran; John Blangero; Peter J Meikle
Journal:  J Lipid Res       Date:  2013-07-18       Impact factor: 5.922

7.  Monounsaturated fatty acids and atherosclerosis: opposing views from epidemiology and experimental animal models.

Authors:  J Mark Brown; Gregory S Shelness; Lawrence L Rudel
Journal:  Curr Atheroscler Rep       Date:  2007-12       Impact factor: 5.113

Review 8.  Oxidized phospholipids and isoprostanes in atherosclerosis.

Authors:  J L Witztum; J A Berliner
Journal:  Curr Opin Lipidol       Date:  1998-10       Impact factor: 4.776

Review 9.  Fatty acids in cardiovascular health and disease: a comprehensive update.

Authors:  Seth J Baum; Penny M Kris-Etherton; Walter C Willett; Alice H Lichtenstein; Lawrence L Rudel; Kevin C Maki; Jay Whelan; Christopher E Ramsden; Robert C Block
Journal:  J Clin Lipidol       Date:  2012-04-13       Impact factor: 5.365

10.  Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study.

Authors:  Christin Stegemann; Raimund Pechlaner; Peter Willeit; Sarah R Langley; Massimo Mangino; Ursula Mayr; Cristina Menni; Alireza Moayyeri; Peter Santer; Gregor Rungger; Tim D Spector; Johann Willeit; Stefan Kiechl; Manuel Mayr
Journal:  Circulation       Date:  2014-03-12       Impact factor: 29.690

View more
  8 in total

1.  Development and application of a high throughput one-pot extraction protocol for quantitative LC-MS/MS analysis of phospholipids in serum and lipoprotein fractions in normolipidemic and dyslipidemic subjects.

Authors:  Michael S Gardner; Zsuzsanna Kuklenyik; Antony Lehtikoski; Kayla A Carter; Lisa G McWilliams; Jennifer Kusovschi; Kevin Bierbaum; Jeffrey I Jones; Jon Rees; Gregory Reis; James L Pirkle; John R Barr
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2019-04-22       Impact factor: 3.205

Review 2.  Lipidomic insight into cardiovascular diseases.

Authors:  Shohei Kohno; Audrey L Keenan; James M Ntambi; Makoto Miyazaki
Journal:  Biochem Biophys Res Commun       Date:  2018-04-19       Impact factor: 3.575

3.  Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney disease.

Authors:  Ana Reis; Alisa Rudnitskaya; Pajaree Chariyavilaskul; Neeraj Dhaun; Vanessa Melville; Jane Goddard; David J Webb; Andrew R Pitt; Corinne M Spickett
Journal:  J Lipid Res       Date:  2014-11-25       Impact factor: 5.922

4.  Association of Lipidomic Profiles With Progression of Carotid Artery Atherosclerosis in HIV Infection.

Authors:  Jin Choul Chai; Amy A Deik; Simin Hua; Tao Wang; David B Hanna; Xiaonan Xue; Sabina A Haberlen; Sanjiv J Shah; Yousin Suh; Jason M Lazar; Deborah Gustafson; Howard N Hodis; Alan L Landay; Kathryn Anastos; Wendy S Post; Robert C Kaplan; Clary B Clish; Qibin Qi
Journal:  JAMA Cardiol       Date:  2019-12-01       Impact factor: 30.154

5.  Lipidome association with vascular disease and inflammation in HIV+ Ugandan children.

Authors:  Sahera Dirajlal-Fargo; Abdus Sattar; Jiao Yu; Zainab Albar; Fabio C Chaves; Ken Riedl; Cissy Kityo; Emily Bowman; Grace A McComsey; Nicholas Funderburg
Journal:  AIDS       Date:  2021-08-01       Impact factor: 4.632

Review 6.  Actionable Metabolic Pathways in Heart Failure and Cancer-Lessons From Cancer Cell Metabolism.

Authors:  Anja Karlstaedt; Walter Schiffer; Heinrich Taegtmeyer
Journal:  Front Cardiovasc Med       Date:  2018-06-19

Review 7.  Nutrigenomics, the Microbiome, and Gene-Environment Interactions: New Directions in Cardiovascular Disease Research, Prevention, and Treatment: A Scientific Statement From the American Heart Association.

Authors:  Jane F Ferguson; Hooman Allayee; Robert E Gerszten; Folami Ideraabdullah; Penny M Kris-Etherton; José M Ordovás; Eric B Rimm; Thomas J Wang; Brian J Bennett
Journal:  Circ Cardiovasc Genet       Date:  2016-04-19

Review 8.  Comprehensive Metabolomic Profiling and Incident Cardiovascular Disease: A Systematic Review.

Authors:  Miguel Ruiz-Canela; Adela Hruby; Clary B Clish; Liming Liang; Miguel A Martínez-González; Frank B Hu
Journal:  J Am Heart Assoc       Date:  2017-09-28       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.